Literature DB >> 9564471

Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine.

A E Silva1, B J McMahon, A J Parkinson, M H Sjogren, J H Hoofnagle, A M Di Bisceglie.   

Abstract

Serum samples from 133 persons who were positive only for antibody to hepatitis B core antigen (anti-HBc) by enzyme immunoassay (EIA) were retested for seromarkers of hepatitis B virus (HBV) by radioimmunoassay and for HBV DNA by polymerase chain reaction analysis. All persons were subsequently vaccinated with hepatitis B vaccine. HBV DNA was found in only five persons, four of whom remained positive during retesting. Most persons had a primary antibody response with three doses of hepatitis B vaccine. Evidence of HBV DNA was not detected in 96% of persons with isolated anti-HBc by EIA.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9564471     DOI： 10.1086/513918

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


  11 in total

1.  Responses to hepatitis B vaccine in isolated anti-HBc positive adults.

Authors:  Jun Yao; Wen Ren; Yongdi Chen; Zhenggang Jiang; Lingzhi Shen; Huan Shan; Xuewei Dai; Jing Li; Ying Liu; Yan Qiu; Jingjing Ren
Journal:  Hum Vaccin Immunother       Date:  2016-04-11       Impact factor: 3.452

2.  Long-term persistence of anti-HBs after hepatitis B vaccination among isolated anti-HBc positive adults in China: 8-years results.

Authors:  Wen Ren; Jing Li; Ruidong Cheng; Zikang Wu; Ying Liu; Yan Qiu; Jun Yao; Jingjing Ren
Journal:  Hum Vaccin Immunother       Date:  2020-09-11       Impact factor: 3.452

3.  Viral hepatitis among drug users in methadone maintenance: associated factors, vaccination outcomes, and interventions.

Authors:  David C Perlman; Ashly E Jordan; Courtney McKnight; Christopher Young; Kevin L Delucchi; James L Sorensen; Don C Des Jarlais; Carmen L Masson
Journal:  J Addict Dis       Date:  2014

4.  Hepatitis B virus DNA in blood samples positive for antibodies to core antigen and negative for surface antigen.

Authors:  C Gutiérrez; G León; C L Loureiro; N Uzcátegui; F Liprandi; F H Pujol
Journal:  Clin Diagn Lab Immunol       Date:  1999-09

5.  Reducing the risk of hepatitis B virus transfusion-transmitted infection.

Authors:  Christoph Niederhauser
Journal:  J Blood Med       Date:  2011-07-18

6.  Challenges in Providing Treatment and Care for Viral Hepatitis among Individuals Co-Infected with HIV in Resource-Limited Settings.

Authors:  Wirach Maek-A-Nantawat; Anchalee Avihingsanon; Pirapon June Ohata
Journal:  AIDS Res Treat       Date:  2012-03-26

Review 7.  Bloodborne viral hepatitis infections among drug users: the role of vaccination.

Authors:  Fabio Lugoboni; Gianluca Quaglio; Paolo Civitelli; Paolo Mezzelani
Journal:  Int J Environ Res Public Health       Date:  2009-01-22       Impact factor: 3.390

8.  Significance of Response to Hepatitis B Recombinant Vaccine in Subjects with Isolated Antibody to Hepatitis B Core Antigen.

Authors:  Ali Bahari; Shahrokh Izadi; Zohreh Bari; Soheyla Khosravi; Bita Baghaei; Esmaeil Saneimoghadam; Farzad Firouzi; Ali Espiari; Abbas Esmaeilzadeh; Ali Mokhtarifar; Alireza Bakhshipour; Azita Ganji
Journal:  Middle East J Dig Dis       Date:  2015-10

9.  Prevention of Hepatitis B Virus Infection in the United States: Recommendations of the Advisory Committee on Immunization Practices.

Authors:  Sarah Schillie; Claudia Vellozzi; Arthur Reingold; Aaron Harris; Penina Haber; John W Ward; Noele P Nelson
Journal:  MMWR Recomm Rep       Date:  2018-01-12

Review 10.  Isolated Anti-HBc: Significance and Management.

Authors:  Florian Moretto; François-Xavier Catherine; Clémentine Esteve; Mathieu Blot; Lionel Piroth
Journal:  J Clin Med       Date:  2020-01-11       Impact factor: 4.241
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.